ModernMedicine Resource Center More Topics

Video

Combination therapy seems best for relief of psoriasis

Combination therapy seems best for relief of psoriasis. Learn about which therapies work in the best combinations for your psoriasis patients.

Treatments for Plaque Psoriasis

Study characterizes safety of pediatric psoriasis treatmentsA retrospective review of pediatric patients treated for psoriasis with systemic agents provides much needed insight about the safety and tolerability of these medications.
Psoriasis patient point of view
Psoriasis patient point of viewSurvey highlights the challenges of controlling psoriasis flares.
A comparison of plaque psoriasis biologics and biosimilarsSwitching from originator to biosimilar shows no significant impact on drug survival in plaque psoriasis, but outcomes differ, researchers report.
Understanding, diagnosing pediatric psoriasis phenotypesA pediatric dermatologist addresses important differences in children with psoriasis, versus adults.
Risankizumab outperforms ustekinumab in psoriasis trial
Risankizumab outperforms ustekinumab in psoriasis trialThe IL-23 inhibitor risankizumab was superior to ustekinumab in a phase two trial of adult patients with moderate-to-severe chronic plaque psoriasis, researchers report.
Psoriasis duration linked to cardiovascular disease riskNew research offers strong evidence that vascular inflammation and risk of having a major adverse cardiovascular event increases with psoriasis duration.
New psoriasis patient profileMetabolomics could provide new statistical methods to help monitor psoriasis disease and progression.
Biologic risk tolerance differs for pregnant patientsOf several biologic agents that women of reproductive age can choose from to treat and manage psoriasis, not all have the same safety profile during pregnancy and lactation periods.
Expense drivers for costliest psoriasis patientsFindings of a recent study challenge the notion that psoriasis patients may be generally healthy and only acquire expenses related to their medications or psoriasis.
Dermatologists collaborate on data-driven pediatric psoriasis researchA global community of physicians cooperated to share experiences with systemic drugs for pediatric psoriasis, and to get experience with a joint registry. A uniform dataset could be tapped to learn more about disease manifestations and treatment outcomes